Gilda Marquina Rodriguez

Title: Gilda Marquina Rodriguez: Innovator in Vaccine Compositions

Introduction

Gilda Marquina Rodriguez is a prominent inventor based in Habana, Cuba. She has made significant contributions to the field of immunology, particularly in the development of vaccine compositions aimed at eliciting immune responses against breast cancer.

Latest Patents

Gilda holds two patents that focus on novel uses for n-glycolylated gangliosides and N-acetylated gangliosides. Her inventions provide methods for obtaining these gangliosides, as well as vaccine compositions that incorporate them. The gangliosides can be coupled to carriers and may include adjuvants. These vaccine compositions are designed to treat breast cancers by eliciting an immune response to corresponding gangliosides present on breast tumor cells.

Career Highlights

Gilda is affiliated with the Centro de Inmunología Molecular, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of vaccine compositions and their applications in cancer treatment.

Collaborations

Gilda collaborates with notable colleagues, including Rolando Perez Rodriguez and Luis Enrique Molina. Their combined expertise contributes to the innovative research being conducted at their institution.

Conclusion

Gilda Marquina Rodriguez is a trailblazer in the field of vaccine development, with her innovative patents paving the way for new treatments in breast cancer. Her contributions to immunology are invaluable and continue to inspire future research.